- Home
- HUMAW vs WDAY Comparison
HUMAW vs WDAY Comparison
Compare HUMAW & WDAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUMAW
- WDAY
- Stock Information
- Founded
- HUMAW 2004
- WDAY 2005
- Country
- HUMAW United States
- WDAY United States
- Employees
- HUMAW 220
- WDAY N/A
- Industry
- HUMAW Biotechnology: Pharmaceutical Preparations
- WDAY EDP Services
- Sector
- HUMAW Health Care
- WDAY Technology
- Exchange
- HUMAW Nasdaq
- WDAY Nasdaq
- Market Cap
- HUMAW N/A
- WDAY N/A
- IPO Year
- HUMAW N/A
- WDAY 2012
- Fundamental
- Price
- HUMAW $0.49
- WDAY $222.22
- Analyst Decision
- HUMAW
- WDAY Buy
- Analyst Count
- HUMAW 0
- WDAY 27
- Target Price
- HUMAW N/A
- WDAY $301.08
- AVG Volume (30 Days)
- HUMAW 14.2K
- WDAY 2.4M
- Earning Date
- HUMAW 03-21-2025
- WDAY 08-21-2025
- Dividend Yield
- HUMAW N/A
- WDAY N/A
- EPS Growth
- HUMAW N/A
- WDAY N/A
- EPS
- HUMAW N/A
- WDAY 1.81
- Revenue
- HUMAW N/A
- WDAY $8,696,000,000.00
- Revenue This Year
- HUMAW N/A
- WDAY $14.87
- Revenue Next Year
- HUMAW N/A
- WDAY $13.05
- P/E Ratio
- HUMAW N/A
- WDAY $122.69
- Revenue Growth
- HUMAW N/A
- WDAY 14.95
- 52 Week Low
- HUMAW $1.18
- WDAY $199.81
- 52 Week High
- HUMAW $1.34
- WDAY $294.00
- Technical
- Relative Strength Index (RSI)
- HUMAW N/A
- WDAY 35.02
- Support Level
- HUMAW N/A
- WDAY $236.17
- Resistance Level
- HUMAW N/A
- WDAY $241.75
- Average True Range (ATR)
- HUMAW 0.00
- WDAY 5.10
- MACD
- HUMAW 0.00
- WDAY -0.33
- Stochastic Oscillator
- HUMAW 0.00
- WDAY 2.73
About HUMAW Humacyte Inc. Warrant
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Advanced Organ Systems, Advanced Tissue Constructs.